RCUS(Arcus Biosciences, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $383.00M | $112.00M | $117.00M | $258.00M | $247.00M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $54.00M | −$280.00M | −$340.00M | −$330.00M | −$386.00M |
| 净利润 | $53.00M | −$267.00M | −$307.00M | −$283.00M | −$353.00M |
| 经营现金流 | −$256.00M | $438.00M | −$306.00M | −$170.00M | −$482.00M |
| 自由现金流 | −$282.00M | $432.00M | −$330.00M | −$176.00M | −$484.00M |
| 摊薄每股收益 | $0.71 | $-3.71 | $-4.15 | $-3.14 | $-3.29 |